National Institute of Allergy andInfectious Diseases (NIAID) http://www.niaid.nih.gov
FOR IMMEDIATE RELEASE
February 26, 2001
A generation ago, it was suggested that the time had come to "close the book" on infectious diseases. With the availability of a growing arsenal of antibiotics and vaccines, some policymakers argued that biomedical research resources should be diverted from infectious diseases to other concerns.
Today, the folly of this position is clear: infectious diseases are the second leading cause of death and the leading cause of disability-adjusted life years worldwide (one disability-adjusted life year is one lost year of healthy life). Together, the five leading infectious causes of death -- acute lower respiratory infections, HIV/AIDS, diarrheal diseases, tuberculosis, and malaria -- took more than 11.5 million lives in 1999 alone.
Rather than becoming a minor concern, “The discipline of infectious diseases will assume added prominence in the 21st century in both developed and developing nations,” writes Anthony S. Fauci, M.D., director of the National Institute of Allergy and Infectious Diseases in the March 1 Clinical Infectious Diseases. “To an unprecedented extent, issues related to infectious diseases in the context of global health are on the agendas of world leaders, health policymakers, and philanthropies.”
He notes that infectious diseases, long viewed solely as humanitarian concerns, are now seen by leaders in the context of foreign policy because of their deleterious effects on economic development and political stability. He suggests that infectious diseases and the biological sciences will be increasingly important to the development and execution of foreign policy in the 21st century.
In his article, Dr. Fauci reviews key scientific challenges facing infectious disease researchers in the new millennium, including the following:
Fortunately, Dr. Fauci writes, “Interest in global health has led to increasing levels of financial support, which, combined with recent technological advances, provide extraordinary opportunities for infectious disease research in the 21st century.”
In the 21st century, the technological advances that will serve as the foundation for the control of established, emerging, and re-emerging diseases will include:
In particular, Dr. Fauci notes that “the sequencing of human and microbial genomes and advances in functional genomics will underpin significant progress in many areas, including understanding human predisposition and susceptibility to disease, microbial pathogenesis, and the development new diagnostics, vaccines, and therapies.”
Dr. Fauci’s article, entitled “Infectious Diseases: Considerations for the 21st Century” is a shortened and edited version of an address Dr. Fauci delivered at the 38th annual meeting of the Infectious Diseases Society of America on September 7, 2000 in New Orleans. Video of the lecture is available at http://www.niaid.nih.gov/about/directors/default.htm.
NIAID conducts and supports research—at NIH, throughout the United States, and worldwide—to study the causes of
infectious and immune-mediated diseases, and to develop better means of preventing, diagnosing and treating these illnesses. News
releases, fact sheets and other NIAID-related materials are available on the NIAID Web site at www.niaid.nih.gov.
About the National Institutes of Health (NIH): NIH, the nation's medical research agency, includes 27 Institutes and Centers and is a component of the U.S.
Department of Health and Human Services. NIH is the primary federal agency conducting and supporting basic, clinical, and translational medical research,
and is investigating the causes, treatments, and cures for both common and rare diseases. For more information about NIH and its programs, visit www.nih.gov.
NIH...Turning Discovery Into Health ®
back to top
Last Updated February 28, 2001